Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

52 million with pre-existing conditions could be denied coverage if ACA repealed

If pre-Affordable Care Act (ACA) health insurance regulations returned with a repeal of the law, 52 million people under the age of 65—27 percent of the U.S. population—could be denied coverage on the individual market due to pre-existing conditions.

Physicians likely to have an ally in Tom Price at HHS

The nominee to run HHS under President-elect Donald Trump has a history of putting doctors’ interests first.

‘Dramatic slowdown’ in value-based care transition—and how Congress can jumpstart it

Members of the American Medical Group Association (AMGA) reported the transition to value-based care is slower than expected, with more multispecialty medical groups and integrated systems predicting fee-for-service (FFS) payments will take up a greater percentage of revenues in the next few years than originally projected.

Medicaid expansion in New York now covers transgender healthcare

Youths in New York are now covered by Medicaid to receive gender-transition care, according to a recent report from the Wall Street Journal.

Maryland co-op suspended from individual market

Evergreen Health Cooperative won’t be able to issue or renew plans for 2017 until regulators decide whether it can convert into a for-profit insurer.

What’s working against ACA repeal

The death of the Affordable Care Act (ACA) has looked all but certain since the election of Donald Trump. Debate has focused on how and when, not if, the law would be rolled back, but one Democratic healthcare lobbyist is offering a different scenario.

Thumbnail

FDA releases new hearing aid guidance, in effect immediately

The FDA has issued a release that details ways to improve access to hearing aids for the 30 million Americans currently suffering from hearing loss. The guidance document will take effect immediately.

Thumbnail

$6.3 billion 21st Century Cures Act passes in big win for drug companies, device makers

The U.S. Senate has approved a bill aimed at speeding up regulatory approval for pharmaceuticals and medical devices, as well as providing extra funding for medical research, the Precision Medicine Initiative, and the cancer “moonshot.”

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup